Research Radboudumc Technology Centers Radboud Biobank News Biobank First implications of the Radboud Biobank new business model

15 July 2025

It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model. The first periodic invoices have now been sent to biobank collections and projects that are actively collecting samples. In addition, the new rates for the issuance of samples from biobank collections have been implemented, i.e. a graduated fee for samples (<10: €1,00 per sample – 10-99: €0,75 per sample - ≥100: €0,50 per sample), lab technicians labor costs, and eventual material and transport costs. Note: the graduated fee for samples does not apply to projects, but the remaining costs will be charged to the applicant. If you are interested in an estimate of the costs for an issuance, you can contact the Radboud Biobank.

  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


Farewell Dorine Swinkels

1 September 2026

On Friday, September 4th, 2026, Dorine Swinkels will retire as Professor of Experimental Clinical Chemistry at Radboudumc. She is also leaving the Radboud Biobank.

go to page

Greening Radboud Biobank – reduction number of aliquots in storage for future initiatives

1 September 2026

Like LUMC and NKI, the Radboud Biobank will also store fewer aliquots per collection tube.

go to page

Effect of Fit & Funding on external invoices

1 September 2026

The Radboud Biobank not only manages issuances and projects for Radboudumc but also provides external services. The Radboud Biobank invoices the external organization for these services.

go to page

New link between iLES and Castor EDC connects clinical data and biobank material

1 September 2026

The Biobank Information Management System, iLES, is now linked to Castor EDC. This development was realized within a KWF-funded project.

go to page

Radboud Biobank's 2025 annual report

3 March 2026

The Radboud Biobank's 2025 annual report is now available on request.

go to page

Aevai Health developed a virtual assistant

3 March 2026

Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.

go to page